Gosset Ownership
Private
Employees
~2000
Stage
Commercial
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Modalities
Cytel General Information
Cytel is a global leader in statistical software development and contract research services specializing in adaptive clinical trial design, advanced analytics, real-world evidence generation, and biometrics. The company’s platforms are widely used by major biopharma companies to optimize drug development strategies. It does not have its own drug pipeline but enables successful trials for clients through innovative methodologies like group sequential and adaptive designs.
Contact Information
Website
Primary Industry
Contract Research Organization
Corporate Office
Cambridge, Massachusetts
USA
USA
Drug Pipeline
No pipeline data available
Key Partnerships
OneMedNet, Nested Knowledge
Cytel Funding
No funding data available
To view Cytel's complete valuation and funding history, request access »